A monthly summary of the epidemiological data on selected Vaccine preventable diseases in the WHO European Region Table : Reported cases for the period November 207 October 208 (data as of 30 November 208) Population in 208 Incidence Rate Nov 7 - Oct 8 cases Month and year of rash onset Nov-7 Dec-7 Jan-8 Feb-8 Mar-8 Apr-8 May-8 Jun-8 Jul-8 Aug-8 Sep-8 Oct-8 Month & year of last report Albania 2 99 422 484.00 43 5 3 63 64 345 359 245 34 45 3 7 20 Oct-8 Andorra 68 95 0.00 0 0 0 0 0 0 0 0 0 0 0 0 0 Oct-8 Armenia 3 034 998 5.93 8 0 0 0 2 4 0 0 0 0 0 Oct-8 Austria 8 63 647 9.52 82 8 7 8 4 6 6 3 6 Oct-8 Azerbaijan 0 070 075 0.20 2 0 0 0 0 0 0 0 0 0 0 0 2 Oct-8 Belarus 9 429 02 23.86 225 0 0 0 7 4 53 58 3 23 2 7 Oct-8 Belgium 53 025 9.47 09 3 6 9 24 22 3 4 4 Oct-8 Bosnia and Herzegovina 3 782 297 24.59 93 3 0 5 7 4 3 34 3 4 0 0 0 Oct-8 Bulgaria 6 992 50.4 8 0 0 0 2 0 3 0 0 0 Oct-8 Croatia 4 94 538 5.48 23 0 0 0 0 0 2 6 3 0 0 Oct-8 Cyprus 98 98 2.52 5 0 5 7 2 0 0 0 0 0 0 0 Oct-8 Czech Republic 0 563 6.95 79 9 5 8 5 0 68 4 6 5 7 4 Oct-8 Denmark 5 732 73.05 6 0 0 0 0 3 0 0 0 0 2 0 Oct-8 Estonia 302 40 7.68 0 0 0 0 0 4 6 0 0 0 0 0 0 Oct-8 Finland 5 556 439.26 7 0 0 0 0 0 3 0 0 3 0 0 Oct-8 France 65 205 67 43.9 2863 65 237 55 760 620 250 90 8 29 37 68 Oct-8 Georgia 3 973 68 396.36 575 3 60 25 59 58 22 253 2 63 60 47 05 Oct-8 Germany 80 560 850 6.77 545 2 9 29 34 62 00 89 02 42 25 26 5 Oct-8 Greece 0 87 762 26.4 2842 304 346 466 454 50 37 249 2 29 8 2 0 Oct-8 Hungary 9 754 429.33 3 0 0 2 5 6 0 0 0 0 0 0 0 Oct-8 Iceland 336 938 2.97 0 0 0 0 0 0 0 0 0 0 0 Oct-8 Ireland 4 790 845 20.46 98 9 3 9 9 9 4 7 6 6 4 Oct-8 Israel 8 455 489 54.22 304 0 0 0 0 9 34 35 74 75 36 39 622 Oct-8 Italy 59 788 04 42.68 2552 66 3 23 296 374 467 428 275 27 69 49 75 Oct-8 Kazakhstan 8 256 484 0.77 4 0 0 0 0 0 0 - - 4 8 Oct-8 Kyrgyzstan 6 23 44 93.5 58 2 2 30 5 33 69 75 99 60 29 74 93 Oct-8 Latvia 935 780.36 22 0 5 8 2 0 2 3 0 0 - Sep-8 Lithuania 2 87 402 0.7 2 0 0 0 0 0 0 0 0 0 0 Oct-8 Luxembourg 59 26 6.77 4 0 0 0 0 0 0 0 2 0 0 Oct-8 Malta 42 387.87 5 0 0 0 0 0 0 0 0 5 0 0 0 Oct-8 Monaco 38 66 0.00 0 0-0 0 0 0-0 0 0 0 0 Oct-8 Montenegro 626 240 324.6 203 0 0 2 4 54 60 47 6 0 0 0 0 Oct-8 Netherlands 7 084 53.29 22 0 0 0 2 2 0 3 0 4 0 0 Oct-8 Norway 5 387 342 2.23 2 0 0 0 4 2 2 0 2 0 0 Oct-8 Poland 38 522 728 3.48 34 2 6 2 8 6 9 3 7 4 6 Oct-8 Portugal 0 229 432 3.20 35 0 0 0 4 08 3 0 3 3 3 0 Oct-8 Republic of Moldova 4 044 534 77.4 32 0 0 2 0 2 23 0 245 20 8 Oct-8 Romania 9 05 089 84.27 60 338 329 0 02 05 04 00 92 63 54 Oct-8 Russian Federation 43 26 490 5.38 2204 94 88 292 292 36 252 28 28 93 23 7 Oct-8 San Marino 32 24 0.00 0 0 0 0 0 0 0 0 0 0 0 0 0 Oct-8 Serbia 8 742 764 655.97 5735 286 392 90 230 522 684 447 70 49 6 5 23 Oct-8 Slovakia 5 434 237 90.7 490 0 8 0 2 3 23 87 262 63 26 5 Oct-8 Slovenia 2 073 08 4.82 0 0 2 0 0 0 3 3 0 0 0 Oct-8 Spain 46 6 884 4.99 230 6 4 53 5 4 25 4 6 4 4 Oct-8 Sweden 9 987 062 5. 5 0 6 2 3 4 3 2 5 3 Oct-8 Switzerland 8 523 590 5.98 5 4 0 7 6 6 3 3 2 4 3 2 Oct-8 Tajikistan 9 046 723 0.00 0 0 0 0 0 0 0 0 0 0 0 0 0 Oct-8 Republic of Macedonia 2 085 35 23.98 50 0 5 5 0 3 24 7 2 Oct-8 Turkey 8 086 257 6.52 529 4 5 2 5 5 77 6 65 85 63 0 Oct-8 Turkmenistan 5 565 070 0.00 0 0 0 0 0 0 0 0 0 0 0 0 0 Oct-8 Ukraine 44 70 002 849.47 3752 00 400 3030 3099 268 382 5629 4882 3877 257 848 3808 Oct-8 United Kingdom 65 92 569 5.46 09 65 46 55 8 49 20 54 00 8 55 6 6 Oct-8 Uzbekistan 3 064 765 0.55 7 0 0 0 0 0 0 2 7 7 0 0 Oct-8 /Averages 97 084 469 70.82 64946 2352 3023 5645 6588 738 7655 8704 7037 5308 3625 2650 4978 Data source: Monthly aggregated and case-based data reported by Member States to WHO/Europe or via ECDC/TESSy. Member States submitting aggregate data: Belgium, Bosnia and Herzegovina, Kazakhstan, Serbia, the former Yugoslav, Ukraine. Data source: "World Population Prospects: The 205 Revision", New York, United Nations. 2 Incidence rates not achieving the target (< per million population) are highlighted in red. For tables -4, the reporting of these data by year and month are based on cases with disease onset date during the above 2-month period and corresponding month. Where the disease onset date was unavailable, cases with the date of notification reported during these respective time periods were included as date of onset. These reports produced by national or partner agencies may differ if other dates (e.g. date of case reporting) were used. No. /208
Table 2: Reported rubella cases for the period November 207 October 208 (data as of 30 November 208) Population in 208 Incidence Rate Nov 7 - Oct 8 population)2 rubella cases Month and year of rash onset Nov-7 Dec-7 Jan-8 Feb-8 Mar-8 Apr-8 May-8 Jun-8 Jul-8 Aug-8 Sep-8 Oct-8 Month & year of Albania 2 99 422 0.00 0 0 0 0 0 0 0 0 0 0 0 0 0 Oct-8 Andorra 68 95 0.00 0 0 0 0 0 0 0 0 0 0 0 0 0 Oct-8 Armenia 3 034 998 0.00 0 0 0 0 0 0 0 0 0 0 0 0 0 Oct-8 Austria 8 63 647 2.09 8 6 7 5 0 0 0 0 0 0 0 0 0 Oct-8 Azerbaijan 0 070 075 0.00 0 0 0 0 0 0 0 0 0 0 0 0 0 Oct-8 Belarus 9 429 02 0. 0 0 0 0 0 0 0 0 0 0 0 Oct-8 Belgium 3 53 025 - - - - - - - - - - - - - - - Bosnia and Herzegovina 3 782 297 0.53 2 0 0 0 0 0-0 0 0 0 Oct-8 Bulgaria 6 992 50 0.4 0 0 0 0 0 0 0 0 0 0 0 Oct-8 Croatia 4 94 538 0.00 0 0 0 0 0 0 0 0 0 0 0 0 0 Oct-8 Cyprus 98 98 0.00 0 0 0 0 0 0 0 0 0 0 0 0 0 Oct-8 Czech Republic 0 563 0.9 2 0 0 0 0 0 0 0 0 0 0 Oct-8 Denmark 3 5 732 73 - - - - - - - - - - - - - - - Estonia 302 40 0.00 0 0 0 0 0 0 0 0 0 0 0 0 0 Oct-8 Finland 5 556 439 0.00 0 0 0 0 0 0 0 0 0 0 0 0 0 Oct-8 France 3 65 205 67 - - - - - - - - - - - - - - - Georgia 3 973 68 0.25 0 0 0 0 0 0 0 0 0 0 0 Oct-8 Germany 80 560 850 0.72 58 4 2 7 3 5 5 3 8 6 6 6 3 Oct-8 Greece 0 87 762 0.00 0 0 0 0 0 0 0 0 0 0 0 0 0 Oct-8 Hungary 9 754 429 0.00 0 0 0 0 0 0 0 0 0 0 0 0 0 Oct-8 Iceland 336 938 0.00 0 0 0 0 0 0 0 0 0 0 0 0 0 Oct-8 Ireland 4 790 845 0.63 3 0 0 0 0 0 0 0 0 0 Oct-8 Israel 8 455 489 0.24 2 0 0 0 0 0 0 0 0 0 0 Oct-8 Italy 59 788 04 0.40 24 2 2 2 2 4 2 2 3 2 2 0 Oct-8 Kazakhstan 8 256 484 0.05 0 0 0 0 0 0 0-0 - 0 Oct-8 Kyrgyzstan 6 23 44.6 0 4 0 3 0 0 0 0 0 0 Oct-8 Latvia 935 780.55 3 0 0 0 0 0 0 0 0 - Sep-8 Lithuania 2 87 402 0.35 0 0 0 0 0 0 0 0 0 0 0 Oct-8 Luxembourg 59 26 0.00 0 0 0 0 0 0 0 0 0 0 0 0 0 Oct-8 Malta 42 387 0.00 0 0 0 0 0 0 0 0 0 0 0 0 0 Oct-8 Monaco 3 38 66 - - - - - - - - - - - - - - - Montenegro 626 240 0.00 0 0 0 0 0 0 0 0 0 0 0 0 0 Oct-8 Netherlands 7 084 53 0.00 0 0 0 0 0 0 0 0 0 0 0 0 0 Oct-8 Norway 5 387 342 0.00 0 0 0 0 0 0 0 0 0 0 0 0 0 Oct-8 Poland 38 522 728 2.2 467 3 33 36 43 42 47 58 50 39 38 2 29 Oct-8 Portugal 0 229 432 0.49 5 0 0 0 0 0 0 2 0 0 Oct-8 Republic of Moldova 4 044 534 0.00 0-0 0 0 0 0 0 0 0 0 0 0 Oct-8 Romania 9 05 089 0.37 7 0 0 0 0 0 Oct-8 Russian Federation 43 26 490 0.03 4 0 0 0 0 0 3 0 0 0 0 0 Oct-8 San Marino 32 24 0.00 0 0 0 0 0 0 0 0 0 0 0 0 0 Oct-8 Serbia 8 742 764 - - - - - - - - - - - - - - No Report Slovakia 5 434 237 0.8 0 0 0 0 0 0 0 0 0 0 0 Oct-8 Slovenia 2 073 08 0.00 0 0 0 0 0 0 0 0 0 0 0 0 0 Oct-8 Spain 46 6 884 0.07 3 0 0 0 0 0 0 0 0 0 Oct-8 Sweden 9 987 062 0.00 0 0 0 0 0 0 0 0 0 0 0 0 0 Oct-8 Switzerland 8 523 590 0.23 2 0 0 0 0 0 0 0 0 0 0 Oct-8 Tajikistan 9 046 723 0.00 0-0 0 0 0 0 0 0 0 0 0 0 Oct-8 2 085 35 0.00 0 0 0 0 0 0 0 0 0 0 0 0 0 Oct-8 Turkey 8 086 257 0.5 2 0 0 0 4 3 0 0 Oct-8 Turkmenistan 5 565 070 0.00 0 0 0 0 0 0 0 0 0 0 0 0 0 Oct-8 Ukraine 44 70 002 4.75 20 - - 24 42 7 32 20 2 28 5 9 Oct-8 United Kingdom 65 92 569 0.05 3 0 0 0 0 0 0 0 0 0 Oct-8 Uzbekistan 3 064 765 0.00 0 0 0 0 0 0 0 0 0 0 0 0 0 Oct-8 /Averages 97 084 469 0.92 84 46 46 82 96 75 96 9 78 62 77 48 44 Data source: Monthly aggregated and case-based data reported by Member States to WHO/Europe or via ECDC/TESSy. Member States submitting aggregate data: Bosnia and Herzegovina, Kazakhstan, Poland, the former Yugoslav, Ukraine. Data source: "World Population Prospects: The 205 Revision", New York, United Nations. 2 Incidence rates not achieving the target (< per million population) are highlighted in red. 3 does not have a comprehensive rubella surveillance system. No. /208
Table 3: Measles classification, reporting and surveillance performance, January October 208 (data as of 30 November 208) 207 (as of 30 November 208) 208 Population in Incidence 208 Rate death Annualized Incidence Rate Lab confirmed Classification Epi-Link Clinically compatible 4 Discarded Measles Imported cases Measles Death Completeness 5 Report Timeliness 5 Month & year of Laboratory investigation rate 5 Surveillance Indicators 7 Rate of discarded cases 6 Origin of infection 5 Timeliness of investigation 5 Albania 8 2 99 422 0.69 2 0 397.34 405 308 0 97 227 3 2 00% 40% Oct-8 97% 42.0 00.0% 78% Andorra 68 95 0.00 0-0.00 0 0 0 0 0 0-00% 00% Oct-8-0.0 - - Armenia 3 034 998 0.00 0 4.67 8 8 0 0 22 0 00% 80% Oct-8 00% 7.0 83.3% 00% Austria 8 63 647 9.64 94 0 5.22 73 66 6 24 9 0 00% 00% Oct-8 78% 0.3 00.0% 6% Azerbaijan 0 070 075 0.00 0 0 0.7 2 0 0 2 0 0 0 00% 00% Oct-8 98%. 0 00% Belarus 8 9 429 02 0.00 0 9.80 225 225 0 0 389 0 00% 50% Oct-8 00% 4. 0.4% 0 Belgium 53 025 3.88 367 0 7.60 05 86 8-0 0 00% 00% Oct-8 - - - - Bosnia and Herzegovina 3 782 297 7.4 27 0 9.83 90 45 0 45-0 0 00% 50% Oct-8 - - - - Bulgaria 6 992 50 23.45 65 0.36 8 8 0 0-5 0 00% 00% Oct-8 00% - 00.0% 00% Croatia 4 94 538.67 7 0 2.78 23 23 0 0 4 9 0 00% 90% Oct-8 00% 0. 00.0% 0 Cyprus 98 98 0.83 4 0 6.26 4 4 0 0-5 0 00% 00% Oct-8 00% - 00.0% 0 Czech Republic 0 563 3.44 46 0 0.8 69 68 0-32 0 00% 80% Oct-8 0% - 00.0% 0 Denmark 5 732 73 0.35 4 0 0.58 6 6 0 0-2 0 00% 00% Oct-8 00% - 00.0% 0 Estonia 302 40 0.00 0 4.48 0 0 0 0 5 3 0 00% 00% Oct-8 00% 3.9 00.0% 00% Finland 5 556 439 0.72 0 0 0.60 7 7 0 0-3 0 00% 00% Oct-8 00% - 42.9% 0 France 65 205 67 7.50 58 34.47 2787 354 560 873-90 3 00% 00% Oct-8 80% - 83.3% 0 Georgia 3 973 68 23.66 96 0 34.99 502 7 78 253 449 0 2 00% 60% Oct-8 87%.3 99.3% 97% Germany 80 560 850 0.80 936 4.77 54 430 54 30-53 0 00% 00% Oct-8 92% - 80.9% 0 Greece 0 87 762 97.87 067 2 67.79 292 233 492 467 69 3 2 00% 00% Oct-8 74% 0.6 9.9% 0 Hungary 9 754 429 3.8 36 0 0.60 3 3 0 0 20 6 0 00% 00% Oct-8 00% 0.2 92.3% 9% Iceland 336 938 2.97 3 0 0.00 0 0 0 0-0 - 00% 00% Oct-8 - - - - Ireland 4 790 845 5.22 25 0 4.26 86 73 2-4 0 00% 00% Oct-8 98% - 70.9% 86% Israel 8 455 489.77 6 0 28.22 304 444 76 99-3 0 00% 70% Oct-8 82% - 0.2% 88% Italy 59 788 04 89.50 5396 5 32.34 2373 823 58 392 87 53 7 00% 00% Oct-8 84% 0.3 88.3% 0 Kazakhstan 8 256 484 0. 2 0 0.64 4 3 0-0 0 80% 80% Oct-8 - - - - Kyrgyzstan 8 6 23 44 0.48 5 0 76.58 577 456 86 35 647 6 2 00% 70% Oct-8 74% 0.4 00.0% 84% Latvia 935 780 2.07 5 0 5.7 7 7 0 0-5 0 90% 90% Sep-8 00% - 29.4% 00% Lithuania 2 87 402 0.00 2 0 0.00 2 2 0 0-2 0 00% 90% Oct-8 00% - 00.0% 50% Luxembourg 59 26.69 4 0 0.00 3 3 0 0-3 0 00% 00% Oct-8 00% - 00.0% 00% Malta 42 387 0.00 0 -.98 5 5 0 0-4 0 00% 00% Oct-8 00% - 00.0% 0 Monaco 38 66 0.00 0-0.00 0 0 0 0 0 0-90% 70% Oct-8-0.0 - - Montenegro 626 240 0.00 0 0 250.7 203 76 4 23 69 5 0 00% 30% Oct-8 93%.0 5.7% 95% Netherlands 7 084 53 0.59 6 0 0.68 22 20 2 0-8 0 00% 00% Oct-8 0% - 00.0% 0 Norway 5 387 342 0.00 0 0.93 2 0 2 0-6 0 00% 00% Oct-8 00% - 83.3% 00% Poland 38 522 728.38 63 0 2.06 26 99 7 20-3 0 00% 00% Oct-8 83% - 00.0% 00% Portugal 0 229 432 3.3 34 0.0 35 26 0 9 346 0 00% 90% Oct-8 96% 3.4 9.% 74% Republic of Moldova 4 044 534 0.00 0 0 6.8 32 76 36 0 55 2 0 00% 90% Oct-8 00%.4 00.0% 00% Romania 9 05 089 452.65 8673 23 40.39 943 768 56 9-7 22 00% 00% Oct-8 98% - 00.0% 00% Russian Federation 43 26 490 6.09 898 0 0.2 822 753 57 2 2360 66 3 00% 00% Oct-8 99%.6 00.0% 44% San Marino 32 24 0.00 0-0.00 0 0 0 0 0 0-00% 80% Oct-8-0.0 - - Serbia 8 742 764 80.29 702 482.02 5057 2638 0 249-0 4 00% 00% Oct-8 - - - - Slovakia 5 434 237.29 0 0 72.53 482 298 84 0 9 0 00% 00% Oct-8 % 0.2 98.8% 00% Slovenia 2 073 08 2.89 8 0 2.4 9 9 0 0-3 0 00% 00% Oct-8 89% - 44.4% 00% Spain 46 6 884 2.9 57 0 3.38 28 22 4 2 03 3 0 00% 00% Oct-8 99% 0.2 8.3% 97% Sweden 9 987 062 3.50 46 0.50 35 35 0 0-7 0 00% 00% Oct-8 97% - 97.% 0 Switzerland 8 523 590.50 05 2.64 47 40 7 0 4 20 0 00% 00% Oct-8 00%.3 95.7% 29% Tajikistan 9 046 723 7.96 65 0 0.00 0 0 0 0 54 0 0 00% 90% Oct-8 00% 0.6-87% 2 085 35 9.59 20 0 9.58 49 38 0-0 0 00% 70% Oct-8 - - - - Turkey 8 8 086 257 0.8 69 0 4.67 50 508 2785 56 0 00% 60% Oct-8 00% 3.4 20.2% 98% Turkmenistan 5 565 070 0.00 0-0.00 0 0 0 0 45 0 0 00% 0% Oct-8 00% 0.8-00% Ukraine 44 70 002 08.26 4782 5 662.59 3520 5952 0 2968-0 5 00% 80% Oct-8 - - - - United Kingdom 65 92 569 2.32 280 0 0.0 908 908 0 0-6 0 00% 90% Oct-8 00% - 97.9% 0 Uzbekistan 3 064 765 0.00 0 0 0.46 7 7 0 0 75 0 0 00% 90% Oct-8 00% 0.2 00.0% 00% /Averages 97 084 469 27.28 25465 4 53.46 5957 22804 2786 3398 9406 743 72 99.2% 86.8% 89.6% 2.0 23.5% 5.9% Data source: Monthly aggregated and case-based data reported by Member States to WHO/Europe or via ECDC/TESSy. Member States submitting aggregate data: Belgium, Bosnia and Herzegovina, Kazakhstan, Serbia, the former Yugoslav, Ukraine. Data source: " World Population Prospects: The 205 Revision", New York, United Nations. 2 Incidence rates not meeting the target (< per million population) are highlighted in red. Imported cases are excluded from the numerator while calculating the incidence rate. 3 All confirmed cases regardless of origin. 5 Target (>=80%) not achieving are highlighted in red. 4 Unless specified as laboratory confirmed or epi-linked, cases are classified as clinically compatible. 6 Rate of discarded cases not achieving the target (>=2 discarded cases per 00 000) are highlighted in red. Rate of discarded cases is not calculated for the countries submitting only confirmed cases. 7 Surveillance indicators could not be calculated for Member States submitting aggregate data. 8 classifies discard cases as discarded, not, not rubella. No. /208
Table 4: Rubella classification, reporting and surveillance performance, January October 208 (data as of 30 November 208) 207 (as of 30 November 208) 208 Population in 208 Incidence Rate rubella Annualized Incidence Rate rubella Lab confirmed Classification Epi-Link Clinically compatible 4 Discarded Rubella Imported cases Completeness 5 Report Timeliness 5 Month & year of Laboratory investigation rate 5 Surveillance Indicators 7 Rate of discarded cases 6 Origin of infection 5 Timeliness of investigation 5 Albania 8 2 99 422 0.00 0 0.00 0 0 0 0 227 0 00% 40% Oct-8 00% 42.0-72% Andorra 68 95 0.00 0 0.00 0 0 0 0 0 0 00% 00% Oct-8-0.0 - - Armenia 3 034 998 0.00 0 0.00 0 0 0 0 0 0 00% 80% Oct-8-0.0 - - Austria 8 63 647 4.53 42 0.48 5 5 0 0-0 00% 00% Oct-8 00% - 00% 0% Azerbaijan 0 070 075 0.00 0 0.00 0 0 0 0 6 0 00% 00% Oct-8 00% 0.6-00% Belarus 8 9 429 02 0. 0.00 0 0 389 00% 50% Oct-8 00% 4. 00% 0% Belgium 9 53 025 - - - - - - - - - - - - - - - - Bosnia and Herzegovina 3 782 297 0.26 0.44 2 0 0 2-0 90% 40% Oct-8 - - - - Bulgaria 6 992 50 0.00 0 0.2 0 0-0 00% 00% Oct-8 0% - 0% 00% Croatia 4 94 538 0.00 0 0.00 0 0 0 0-0 00% 80% Oct-8 - - - - Cyprus 98 98 0.00 0 0.00 0 0 0 0-0 00% 00% Oct-8 - - - - Czech Republic 0 563 0.09 2 0.6 2 0-0 00% 50% Oct-8 00% - 00% 0% Denmark 9 5 732 73 - - - - - - - - - - - - - - - - Estonia 302 40 0.00 0 0.00 0 0 0 0 0 00% 00% Oct-8 00% 0.8-00% Finland 5 556 439 0.8 0.00 0 0 0 0-0 00% 00% Oct-8 - - - - France 9 65 205 67 - - - - - - - - - - - - - - - - Georgia 3 973 68.26 5 0.00 0 0 0 0 68 0 00% 30% Oct-8 75%.7-96% Germany 80 560 850 0.9 74 0.52 52 0 4-2 00% 00% Oct-8 2% - 56% 0% Greece 0 87 762 0.00 0 0.00 0 0 0 0-0 00% 00% Oct-8 - - - - Hungary 9 754 429 0.00 0 0.00 0 0 0 0 7 0 00% 70% Oct-8 00% 0. - 00% Iceland 336 938 0.00 0 0.00 0 0 0 0-0 00% 00% Oct-8 - - - - Ireland 4 790 845 0.00 0 0.52 3 0 0 3-0 00% 00% Oct-8 33% - 33% 67% Israel 8 455 489 0.00 0 0.20 2 0-0 00% 60% Oct-8 00% - 0% 00% Italy 59 788 04.2 68 0.26 20 6 3 2 00% 00% Oct-8 86% 0.0 65% 0% Kazakhstan 8 256 484 0.00 0 0.05 0 0-0 80% 70% Oct-8 - - - - Kyrgyzstan 8 6 23 44 0.64 4.07 8 8 0 0 647 0 00% 70% Oct-8 60% 0.4 00% 84% Latvia 935 780 0.00 0 0.86 3 3 0 0-90% 80% Sep-8 00% - 00% 33% Lithuania 2 87 402 0.00 0 0.30 0 0-0 00% 90% Oct-8 00% - 00% 0% Luxembourg 59 26 0.00 0 0.00 0 0 0 0-0 00% 00% Oct-8 - - - - Malta 42 387 0.00 0 0.00 0 0 0 0-0 00% 00% Oct-8 - - - - Monaco 9 38 66 - - - - - - - - - - - - - - - - Montenegro 626 240 0.00 0 0.00 0 0 0 0 0 0 00% 30% Oct-8-0.0 - - Netherlands 7 084 53 0.00 0 0.00 0 0 0 0-0 00% 00% Oct-8 - - - - Norway 5 387 342 0.00 0 0.00 0 0 0 0-0 00% 90% Oct-8 - - - - Poland 38 522 728 2.36 476 8.72 403 3 2 398-0 00% 00% Oct-8 - - - - Portugal 0 229 432 0.39 4 0.24 5 3 0 2 9 2 00% 90% Oct-8 79% 0. 00% 57% Republic of Moldova 4 044 534 0.00 0 0.00 0 0 0 0 9 0 00% 80% Oct-8 00% 0.2-00% Romania 9 05 089 0.47 9 0.3 7 4 0 3-0 00% 80% Oct-8 86% - 00% 00% Russian Federation 43 26 490 0.04 7 0.0 3 3 0 0 0 00% 00% Oct-8 00% 0.0 00% 00% San Marino 32 24 0.00 0 0.00 0 0 0 0 0 0 00% 80% Oct-8-0.0 - - Serbia 8 742 764 - - - - - - - - - - - No Report - - - - Slovakia 5 434 237 0.00 0 0.5 0 0-0 00% 00% Oct-8 0% - 00% 00% Slovenia 2 073 08 0.00 0 0.00 0 0 0 0-0 00% 00% Oct-8 - - - - Spain 46 6 884 0.00 0.05 3 2 0 6 0 00% 00% Oct-8 89% 0.0 33% 89% Sweden 9 987 062 0.00 0 0.00 0 0 0 0 0 00% 00% Oct-8 00% 0.0-00% Switzerland 8 523 590 0.2 0.20 2 2 0 0 28 0 00% 00% Oct-8 93% 0.3 50% 0% Tajikistan 9 046 723 0. 0.00 0 0 0 0 23 0 00% 90% Oct-8 00% 0.3-00% 2 085 35 0.00 0 0.00 0 0 0 0-0 00% 60% Oct-8 - - - - Turkey 8 8 086 257 0.00 0 0.2 2 2 0 0 2785 0 00% 60% Oct-8 00% 3.4 25% 00.0% Turkmenistan 5 565 070 0.00 0 0.00 0 0 0 0 46 0 00% 0% Oct-8 00% 0.8-00% Ukraine 44 70 002 - - 3.96 20 2 0 98-0 00% 70% Oct-8 - - - - United Kingdom 65 92 569 0.00 3 0.0 2 2 0 0-00% 80% Oct-8 00% - 00% 0% Uzbekistan 3 064 765 0.03 0.00 0 0 0 0 5 0 00% 90% Oct-8 00% 0.0-00% /Averages 97 084 469 0.75 70 0.67 749 8 6 662 5334 9 9.7% 75.8% 225.4%.2.5% 82.3% Data source: Monthly aggregated and case-based data reported by Member States to WHO/Europe or via ECDC/TESSy. Member States submitting aggregate data: Bosnia and Herzegovina, Kazakhstan, Poland, the former Yugoslav and Ukraine. Data source: World Population Prospects: The 205 Revision", New York, United Nations. 2 Incidence rates not meeting the target (< per million population) are highlighted in red. Imported rubella cases are excluded from the numerator while calculating the incidence rate. 3 All confirmed rubella cases regardless of origin. 4 Unless specified as laboratory confirmed or epi-linked, cases are classified as clinically compatible. 5 Target (>=80%) not achieving are highlighted in red. 6 Rate of discarded cases not achieving the target (>=2 discarded cases per 00 000) are highlighted in red. Rate of discarded cases is not calculated for the countries submitting only confirmed rubella cases. 7 Surveillance indicators could not be calculated for Member States submitting aggregate data. 8 classifies discard cases as discarded, not, not rubella. 9 does not have a comprehensive rubella surveillance system. No. /208
Table 5: Measles and rubella laboratory test results, January October 208 (data as of 30 November 208) Measles Rubella Reporting to CISID / MRLDMS % sequencing % sequencing Genotypes Positive Genotypes % Positive for reported reported % Timeliness specimens reported to specimens for rubella reported to Completeness 4 tested (%) within 60 within 60 MeaNS 2 days 2 tested (%) RubeNS 3 days 3 4 Month of Albania 2532 307 (52.0) B3 0% 0 0 - - 00% 70% Oct-8 Andorra No Lab Armenia 227 8 (8.0) D8 0% 227 0 (0.0) - - 00% 50% Oct-8 Austria 377 60 (4.0) B3,D8 00% 4407 9 (0.0) E,2B 0% 00% 00% Oct-8 Azerbaijan 84 0 (0.0) - - 259 0 (0.0) - - 00% 00% Oct-8 Belarus 705 282 (40.0) B3,D8 00% 424 3 (.0) 2B 00% 00% 90% Oct-8 Belgium 29 05 (36.0) B3,D8 69% 09 8 (7.0) - - 00% 40% Oct-8 Bosnia and Herzegovina 82 30 (37.0) B3 67% 82 4 (5.0) - - 00% 90% Oct-8 Bulgaria 202 20 (0.0) B3 00% 02 0 (0.0) - - 00% 90% Oct-8 Croatia 75 - B3,D8 86% 25 0 (0.0) - - 60% 0% Jun-8 Cyprus 203 8 (9.0) - - 296 0 (0.0) - - 90% 40% Sep-8 Czech Republic 482 63 (34.0) D8 50% 0 0 - - 00% 00% Oct-8 Denmark 85 36 (4.0) B3,D8 00% 38 2 (5.0) - - 00% 00% Oct-8 Estonia 55 7 (.0) - - 326 3 (.0) - - 90% 90% Oct-8 Finland 07 6 (5.0) D8 43% 07 5 (5.0) - - 00% 00% Oct-8 France 55 540 (35.0) B3,D8 5% 559 0 (0.0) 2B 0% 00% 40% Oct-8 Georgia - - - - - - - - - - No Report Germany - - - - - - - - - - No Report Greece 524 444 (85.0) B3 7% 0 0 - - 60% 0% Jun-8 Hungary 246 27 (.0) B3,D8 00% 57 0 (0.0) - - 00% 00% Oct-8 Iceland - - - - - - - - - - No Report Ireland 837 63 (9.0) B3,D8 00% 206 0 (0.0) - - 00% 00% Oct-8 Israel 77 789 (45.0) D8 94% 894 339 (8.0) 2B 00% 00% 80% Oct-8 Italy 22 28 (55.0) B3,D8 40% 054 62 (6.0) - - 00% 90% Oct-8 Kazakhstan 60 4 (23.0) B3,D8 33% 56 (2.0) - - 00% 00% Oct-8 Kyrgyzstan 788 47 (53.0) B3 0% 734 7 (.0) - - 00% 00% Oct-8 Latvia 905 75 (8.0) B3,D8 64% 723 (2.0) - - 00% 60% Oct-8 Lithuania 46 7 (5.0) - - 4 2 (5.0) - - 00% 90% Oct-8 Luxembourg 59 (2.0) B3,D8 00% 0 0 - - 00% 00% Oct-8 Malta 27 8 (4.0) B3,D8 25% 566 0 (0.0) - - 90% 70% Sep-8 Monaco No Lab Montenegro - - - - - - - - No Report Netherlands 60 20 (33.0) B3,D8 00% 56 0 (0.0) - - 00% 00% Oct-8 Norway - - B3,D8 00% - - - - - - No Report Poland - - D8 44% - - - - - - No Report Portugal 048 27 (2.0) B3,D8 22% 4 2 (50.0) - - 00% 80% Oct-8 Republic of Moldova 267 75 (66.0) B3,D8 0% 240 0 (0.0) - - 00% 00% Oct-8 Romania 4626 3856 (83.0) B3,D8 70% 682 9 (.0) - - 00% 70% Oct-8 Russian Federation 6873 2682 (39.0) B3,D8 62% 5734 58 (.0) - - 00% 00% Oct-8 San Marino No Lab Serbia 483 2672 (56.0) B3,D8 0% 272 4 (.0) - - 00% 00% Oct-8 Slovakia 203 62 (3.0) D8 0% 4 0 (0.0) - - 00% 00% Oct-8 Slovenia 255 7 (7.0) B3 00% 04 0 (0.0) - - 00% 00% Oct-8 Spain - - B3,D8,D4 39% - - - - - - No Report Sweden 2534 37 (5.0) B3,D8 00% 655 6 (0.0) - - 00% 60% Oct-8 Switzerland 73 67 (39.0) B3,D8 94% 8 8 (00.0) - - 00% 00% Oct-8 Tajikistan 75 0 (0.0) - - 72 0 (0.0) - - 00% 80% Oct-8 7 7 (4.0) - - 3 0 (0.0) - - 30% 0% May-8 Turkey 549 690 (3.0) B3,D8 3% 4468 87 (2.0) - - 00% 50% Oct-8 Turkmenistan 90 0 (0.0) - - 90 0 (0.0) - - 00% 80% Aug-8 Ukraine 026 503 (49.0) B3,D8 3% 275 0 (4.0) - - 00% 80% Oct-8 United Kingdom 488 005 (2.0) B3,D8 98% 072 7 (.0) - - 00% 00% Oct-8 Uzbekistan 06 7 (6.0) D8 33% 06 0 (0.0) - - 00% 90% Oct-8 / Average 5000 7839 (36%) - 58% 30947 657 (2%) - 29% 77.7% 64.2% Data source: Aggregated monthly data provided by regional and rubella laboratory network (MR Labnet) to WHO/Europe. Some countries are only reporting to specimen-based MR lab data management system (M R LDMS). 2 MeaNS: http://www.who-.org/. Timeliness of sequence reporting relates to the time between specimen collection and reporting to MeaNS. 3 RubeNS: http://www.who-rubella.org/. Timeliness of sequence reporting relates to the time between specimen collection and reporting to RubeNS. 4 Target (>=80%) not achieving are highlighted in red. *Specimen based data are not population based, and should not be interpreted as indicators for epidemiological surveillance. Laboratories may have received more than clinical sample or may have conducted more than test for a given case reported in Table. No. /208
Figure : Ten countries with the highest numbers of cases in the WHO European Region in the previous 2-months November 207 to October 208 (data as of 30 November 208)* Ukraine (n=3752; 58%) Serbia (n=5735; 9%) France (n=2863; 4%) Greece (n=2842; 4%) Italy (n=2552; 4%) Russian Federation (n=2204; 3%) Romania (n=60; 2%) Georgia (n=575; 2%) Albania (n=43; 2%) Israel (n=304; 2%) Out of 64 946 cases reported in the previous 2 month regionally, 59 69 (92%) cases were reported from these 0 countries. 0 5000 0000 5000 20000 25000 30000 35000 40000 Figure 2: Measles cases by month of onset in the WHO European Region, November 207 to October 208 (data as of 30 Number of reported cases 0000 9000 8000 7000 6000 5000 4000 3000 2000 000 0 Other (n=3433) Italy (n=2552) Greece (n=2842) France (n=2863) Serbia (n=5735) Ukraine (n=3752) Nov Dec Jan Feb Mar Apr May Jun Jul Aug Sep Oct 207 208 Figure 3: Age distribution of cases** by proportion (left) and annualized incidence rate (right) in the WHO European Region, January to October 208 (data as of 30 November 208)* (n=59 57) % of reported cases 25% 20% 5% 0% 5% 0% 23% 8% 7% 5% % 0% 8% < 4 5 9 0 4 5 9 20 29 30+ Age group (years) Annualized incidence of reported cases per million inhabitants 400 350 300 250 200 50 00 50 0 354 95 33 00 94 7 9 < 4 5 9 0 4 5 9 20 29 30+ Age group (years) *Data source: Monthly aggregated and case-based data reported by Member States to WHO/Europe or via ECDC/TESSy **The age was not known in 7 cases. Contact us: Vaccine preventable Diseases and Immuniza on Programme, WHO Regional Office for Europe Tel.: +45 45 33 70 00 E mail: eu@who.int and/or eucddata@who.int Web site: h p://www.euro.who.int/vaccine World Health Organiza on, 208. No. /208